Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Feb 7;6(7):e1788. doi: 10.1002/cnr2.1788

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2023 The Authors. Cancer Reports published by Wiley Periodicals LLC.

This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Partial Response in Patient Receiving ICI + SBRT. 83‐year‐old man with right temporal WHO grade IV glioblastoma status‐post resection and adjuvant concurrent radiotherapy and temozolomide who received 30 Gy in five fractions concurrently with 15 cycles of ICI as his third line treatment. Radiotherapy isodose line key shown in (A). Representative (B) axial (C) sagittal and (D) coronal images of his RT plan. Pretreatment MRI (E) axial T1 and (F) axial T2 FLAIR showing 2 × 2.1 cm nodular enhancing mass along anterior/medial margin of the resection cavity. MRI 4 months post‐SBRT (G) axial T1 and (H) axial T2 FLAIR showing overall decrease in size and nodular enhancing component of the lesion.